Our results demonstrated the presence of the EBV genome in a large subset of breast cancers. The virus was restricted to tumor cells and was more frequently associated with the most aggressive tumors. EBV may be a cofactor in the development of some breast cancers.
Cyclooxygenase-2 (COX-2) is an inducible form of COX and is
overexpressed in diverse tumors, raising the possibility of a role for
COX-2 in carcinogenesis. In addition, COX-2 contributes to
angiogenesis. The Epstein–Barr virus (EBV) oncoprotein, latent
membrane protein 1 (LMP1), is detected in at least 70% of
nasopharyngeal carcinoma (NPC) and all EBV-infected preinvasive
nasopharyngeal lesions. We found that in specimens of LMP1-positive
NPC, COX-2 is frequently expressed, whereas LMP1-negative NPC
rarely express the enzyme. We next found that expression of LMP1 in
EBV-negative nasopharyngeal epithelial cells induced COX-2 expression.
Coexpression of IκBα(S32A/S36A), which is not phosphorylated and
prevents NF-κB activation, with LMP1 showed that NF-κB is essential
for induction of COX-2 by LMP1. We also demonstrate that NF-κB is
involved in LMP1-induced
cox-2
promoter activity with
the use of reporter assays. Two major regions of LMP1, designated CTAR1
and CTAR2, are signal-transducing domains of LMP1. Constructs
expressing either CTAR1 or CTAR2 induce COX-2 but to a lesser extent
than wild-type LMP1, consistent with the ability of both regions to
activate NF-κB. Furthermore, we demonstrate that LMP1-induced COX-2
is functional because LMP1 increased production of prostaglandin
E
2
in a COX-2-dependent manner. Finally, we demonstrate
that LMP1 increased production of vascular endothelial growth factor
(VEGF). Treatment of LMP1-expressing cells with the COX-2-specific
inhibitor (NS-398) dramatically decreased production of VEGF,
suggesting that LMP1-induced VEGF production is mediated, at least in
part, by COX-2. These results suggest that COX-2 induction by LMP1 may
play a role in angiogenesis in NPC.
Nasopharyngeal carcinoma (NPC), an EBV-associated malignancy, is highly metastatic compared with other head and neck tumors, perhaps because of its viral link. Here, we show that the principal EBV oncoprotein, latent membrane protein 1 (LMP1), induces epithelial-mesenchymal transition (EMT) via Twist, a master transcriptional regulator in embryogenesis and newly implicated in metastasis, which, in turn, are likely to contribute to the highly metastatic character of NPC. LMP1 could induce EMT and its associated cell motility and invasiveness in a cell culture model, whereas expression of Twist small interfering RNA reversed LMP1-induced EMT. In diverse EBV-infected cell lines, expression of Twist correlates with expression of LMP1. Dominant-negative LMP1 could suppress Twist expression in EBV-positive cells, whereas LMP1 could induce Twist in EBV-negative nasopharyngeal cells. LMP1 signals through the nuclear factor-KB pathway, and an IKB superrepressor inhibited induction of Twist by LMP1. Finally, in human NPC tissues, expression of Twist and LMP1 is directly correlated and expression of Twist is associated with metastasis clinically. These results suggest that induction of Twist by a human viral oncoprotein LMP1 directly contributes to the metastatic nature of NPC. [Cancer Res 2007;67(5):1970-8]
Steroid hormones produce a response in target cells by binding to hormone-specific soluble receptors, which undergo a transformational change, leading to their interaction with chromatin and to modified gene expression. In a previous paper, we described a monoclonal antibody, BF4, that specifically recognizes and binds the non-transformed '8S' form of chicken oviduct progesterone receptor (8S-PR). We now show that BF4 does not form an immune complex with the 4S transformed form of 3H-progestin-labelled progesterone receptor, but does interact with the 8S non-transformed forms of the oestrogen, androgen and glucocorticosteroid receptors. Our results suggest that the antigenic determinant recognized by BF4 is present on a non-hormone binding unit, which we identify as a polypeptide of molecular weight (MW) 90,000 in the case of the progesterone receptor, and that this unit is common to other 8S non-transformed chicken steroid receptors.
In seropositive individuals Epstein-Barr virus (EBV) establishes a virus reservoir in peripheral blood lymphocytes (PBLs). Transmission from one individual to another occurs via saliva due to a lytic (virion productive) phase of infection in the oropharynx. EBNA-1 is responsible for maintaining viral episomes in the host cell and could, therefore, also affect the persistence of the virus in different cell lineages. Based on sequence analysis of EBNA-1 we now demonstrate that (i) in addition to the prototype EBNA-1 (identical to the B95.8 virus EBNA-1), EBV in normal individuals encompasses multiple EBNA-1 subtypes, both in PBLs and in oral
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.